SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MGI Pharma MOGN New patents, anti cancer -- Ignore unavailable to you. Want to Upgrade?


To: tuck who wrote (1661)2/8/2006 8:36:28 PM
From: sammaster  Read Replies (1) | Respond to of 1826
 
i value this company by its price to sales ratio and growth rate...still seems cheap...
i think a lot of bad news already priced into the stock as evidenced by its chart :)
i read some report somewhere that generic zofran wont have as much impact as feared..if that comes to be true then this stock will do well..
and as you mentioned dacogen...plus other pipeline product results could give boost....